MedPath

Polyethylene glycol

Generic Name
Polyethylene glycol
Brand Names
Bi-peglyte, Clearlax, Colyte, Gavilax, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Gentlelax, Gialax, Glycolax, Golytely, Healthylax, Miralax, Moviprep, Nulytely, Peglyte, Pegylax, Plenvu, Purelax, Suflave
Drug Type
Small Molecule
CAS Number
25322-68-3
Unique Ingredient Identifier
3WJQ0SDW1A
Background

Polyethylene glycol (PEG) is a synthetic polymer produced via polymerization of ethylene oxide molecules to make joining units of ethylene glycol by an ether linkage. PEGs are water-soluble polymers that can form hydrogen bonds in a ratio of 100 water molecules per one PEG molecule. Molecular weights of PEGs vary by time of the polymerization process and the molecular weight represents the weighted average of the individual PEG molecules. PEGs differ in their physical and chemical properties depending on their molecular weight: PEGs are liquids when molecular weights are <1000 and the molecule turns to waxy solids with increasing molecular weights. The most common preparations of PEGs include PEG 3350 and PEG 400. PEGs have various applications in many fields, ranging from medical to industrial areas. PEGs have a long history of gastroenterology: PEG 3350 is a common over-the-counter osmotic laxative used to relieve occasional constipation. PEG 3350 is also used for cleansing of the colon in preparation for colonoscopy in adults.

The rationale of using PEG in gastroenterology is due to the physical properties of the compound: its potent water-binding capacity, negligible intestinal absorption with increasing molecular mass, lack of significant toxicity, and limited intestinal enzymatic degradation or bacterial metabolism all make PEG a useful therapeutic agent for the treatment of occasional constipation and bowel cleansing for preparation in colonoscopy.

Indication

Polyethylene glycol is indicated for use as an over-the-counter osmotic laxative to relieve occasional constipation. When used in combination with sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride and potassium chloride, it is used for cleansing of the colon in preparation for colonoscopy in adults.

Associated Conditions
Chronic Constipation, Constipation, Dry Eye Syndrome (DES), Dry Eyes, Occasional Constipation
Associated Therapies
Bowel preparation therapy, Eye lubrication

Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit

Phase 4
Completed
Conditions
Cystic Fibrosis Gastrointestinal Disease
Interventions
Device: SmartPill Motility System & PillCam Patency Capsule
First Posted Date
2019-12-24
Last Posted Date
2024-08-09
Lead Sponsor
St. Louis University
Target Recruit Count
3
Registration Number
NCT04210427
Locations
🇺🇸

SSM Health Saint Louis University Hosptial, Saint Louis, Missouri, United States

🇺🇸

SSM Health Cardinal Glennon Children's Hosptial, Saint Louis, Missouri, United States

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Early Phase 1
Recruiting
Conditions
Metastatic Sarcoma
Recurrent Sarcoma
Resectable Sarcoma
Interventions
First Posted Date
2019-12-13
Last Posted Date
2025-02-28
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
20
Registration Number
NCT04199026
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

Does a Preoperative Bowel Regimen Change Time to First Bowel Movement After Robotic Sacral Colpopexy

Phase 4
Completed
Conditions
Post-Op Complication
Constipation
Interventions
First Posted Date
2019-12-13
Last Posted Date
2024-12-27
Lead Sponsor
Northwell Health
Target Recruit Count
71
Registration Number
NCT04197869
Locations
🇺🇸

Northwell Health, Bay Shore, New York, United States

Study Assessing CLENPIQ As Bowel Preparation for Pediatric Colonoscopy

Phase 1
Recruiting
Conditions
Bowel Preparation
Interventions
First Posted Date
2019-10-02
Last Posted Date
2025-02-05
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
30
Registration Number
NCT04113382
Locations
🇺🇸

Ferring Investigational Site, Bronx, New York, United States

International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma

First Posted Date
2019-08-02
Last Posted Date
2025-03-21
Lead Sponsor
University Hospital Muenster
Target Recruit Count
683
Registration Number
NCT04043494
Locations
🇦🇹

Univ.Klinik für Kinder- und Jugendheilkunde Graz, Klin. Abteilung für pädiatrische Hämato-Onkologie, Graz, Austria

🇦🇹

Univ.Klinik für Kinder- und Jugendheilkunde Innsbruck, Universitätsklinik für Pädiatrie I, Innsbruck, Austria

🇦🇹

Kepler Universitätsklinikum, Med Campus IV / Onkologie, Linz, Austria

and more 223 locations

Effectiveness of Enteral Nutrition for Dose Reduction of Low Dose PEG

Not Applicable
Conditions
Bowel Preparation
Interventions
Dietary Supplement: Enteral Nutrition Powder Ensure
Other: Self-controlled diet
First Posted Date
2019-07-16
Last Posted Date
2019-07-16
Lead Sponsor
Ningbo No. 1 Hospital
Target Recruit Count
248
Registration Number
NCT04021979
Locations
🇨🇳

Ningbo first hospital, Ningbo, Zhejiang, China

Compare Polyethylene Glycol and Sodium Picosulfate Alone or Combined

Not Applicable
Conditions
Bowel Preparation
Interventions
First Posted Date
2019-05-28
Last Posted Date
2019-05-28
Lead Sponsor
Dalin Tzu Chi General Hospital
Target Recruit Count
600
Registration Number
NCT03965182

Efficacy and Safety of PEG 3350 for Treatment of Chronic Constipation

Phase 3
Conditions
Constipation - Functional
Interventions
First Posted Date
2019-05-21
Last Posted Date
2020-10-20
Lead Sponsor
Fakultas Kedokteran Universitas Indonesia
Target Recruit Count
184
Registration Number
NCT03957668
Locations
🇮🇩

Puskesmas Kelurahan Paseban, Jakarta, DKI Jakarta, Indonesia

🇮🇩

Puskesmas Kelurahan Petamburan, Jakarta, DKI Jakarta, Indonesia

🇮🇩

RSUPN dr. Cipto Mangunkusumo (Cipto Mangunkusumo Hospital), Jakarta, DKI Jakarta, Indonesia

Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma

Phase 1
Completed
Conditions
Uveal Melanoma
Interventions
First Posted Date
2019-04-22
Last Posted Date
2025-05-15
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
9
Registration Number
NCT03922880
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Impact of a Predictive Score of Bowel Preparation Quality in Clinical Practice

Phase 4
Completed
Conditions
Cleansing Quality of the Colon
Interventions
Drug: polyethylene glycol plus ascorbic acid
First Posted Date
2019-02-05
Last Posted Date
2020-03-13
Lead Sponsor
Hospital Universitario de Canarias
Target Recruit Count
260
Registration Number
NCT03830489
Locations
🇪🇸

Department of Gastroenterology, La Laguna, S/C De Tenerife, Spain

© Copyright 2025. All Rights Reserved by MedPath